Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bertilsson

Showing results (261-270 of 263) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 263 results.
Annals of the Rheumatic Diseases|May 10, 2008
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics RegisterJ Askling, E Baecklund, F Granath, et al.
Acta Psychiatrica Scandinavica|February 1, 1996
Antidepressants and drug-metabolizing enzymes--expert group reportU A Meyer, R Amrein, L P Balant, et al.
Annals of the Rheumatic Diseases|April 22, 2005
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonistsJ Askling, C M Fored, E Baecklund, et al.
Pageof 27

Showing results (261-270 of 263) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 263 results.
Annals of the Rheumatic Diseases|May 10, 2008
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics RegisterJ Askling, E Baecklund, F Granath, et al.
Acta Psychiatrica Scandinavica|February 1, 1996
Antidepressants and drug-metabolizing enzymes--expert group reportU A Meyer, R Amrein, L P Balant, et al.
Annals of the Rheumatic Diseases|April 22, 2005
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonistsJ Askling, C M Fored, E Baecklund, et al.
Pageof 27